サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1472117

臨床栄養の世界市場規模調査・予測：製品別、適応症別、販売チャネル別、地域別分析、2023年～2030年

Global Clinical Nutrition Market Size Study & Forecast, By Product By Indication, By Sales and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
臨床栄養の世界市場規模調査・予測：製品別、適応症別、販売チャネル別、地域別分析、2023年～2030年
出版日: 2024年04月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床栄養市場は、2022年に約291億2,000万米ドルと評価され、予測期間2023年～2030年には5.34％以上の健全な成長率で成長すると予測されています。

臨床栄養は、さまざまな健康状態を予防、管理、治療するための食事原則の応用に焦点を当てた栄養科学の専門分野です。個人の栄養ニーズ、食習慣、全体的な健康状態を評価し、個人に合った栄養計画を策定します。臨床栄養士は、ヘルスケア専門家と協力して、糖尿病、心血管疾患、肥満、消化器疾患などの特定の医学的懸念に対処します。彼らは生化学、生理学、栄養学の知識を活用し、最適な健康と幸福をサポートする介入策を考案します。臨床栄養市場は、栄養不良の有病率の上昇、慢性疾患の有病率の増加、世界の高齢者人口の増加などの要因によって拡大しています。

栄養不良の有病率の上昇は、臨床栄養市場の成長を支える重要な要因です。必須栄養素の欠乏や不均衡を特徴とする栄養不良は、多様な年齢層や集団の個人に影響を及ぼし、世界の健康上の大きな課題となっています。栄養不良の深刻な結果を考慮すると、この状態に効果的に対処し予防するための重要な対策として臨床栄養を重視し実施する必要があります。臨床栄養製品および介入は、医学的状態、慢性疾患、または不十分な食事摂取のいずれが原因であるかにかかわらず、栄養不良の個人に的を絞った栄養サポートを提供する上で重要な役割を果たします。世界保健機関（WHO）の2022年報告書によると、5歳未満の発育不良とされた子どもは世界で約1億4,900万人に上り、うち4,500万人が栄養不良に陥っています。南アジアサブリージョンでは、この年齢層の子どもたちの栄養不良が大きな負担となっています。国連はアジアにおける懸念すべき動向を報告しており、栄養不良人口は2019年の3億6,130万人から2020年には4億1,800万人に増加し、この期間中に栄養不良率が7.9％から9.0％に上昇します。このように、栄養不良の有病率の上昇が市場成長の原動力となっています。さらに、栄養科学における技術的進歩やヘルスケアインフラの増加が、市場成長の新たな機会を生み出しています。しかし、臨床栄養の高コストと厳しい規制環境が、2023年～2030年の予測期間を通じて市場成長を阻害しています。

臨床栄養の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は2022年の市場を独占しました。同地域の市場は、胃腸障害、代謝障害、神経障害などの慢性疾患にかかりやすい高齢者人口の増加や、重篤な治療を受ける未熟児の増加が市場成長を促進する主な要因となっています。アジア太平洋地域は、高齢者人口の増加、がん、糖尿病、胃腸障害、自己免疫疾患などの様々な疾患の有病率の増加などの要因により、予測期間中に大きく成長すると予想されます。その結果、慢性疾患の食事管理のための臨床栄養の需要が増加すると予想されます。

本調査の目的は、近年のさまざまなセグメント＆国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の臨床栄養市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の臨床栄養市場力学

  • 臨床栄養市場の影響分析（2020年～2030年）
    • 市場促進要因
      • 栄養不良の有病率の上昇
      • 慢性疾患の有病率の増加
      • 高齢者人口の増加
    • 市場の課題
      • 厳しい規制環境
      • 臨床栄養サービスの高コスト
    • 市場機会
      • 栄養科学における技術の進歩
      • ヘルスケアインフラの増加

第4章 世界の臨床栄養市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターのファイブフォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 臨床栄養の世界市場：製品別

  • 市場スナップショット
  • 臨床栄養の世界市場：製品別、実績 - ポテンシャル分析
  • 臨床栄養の世界市場：製品別、推定・予測（2020年～2030年）
  • 臨床栄養市場のサブセグメント分析
    • 経口臨床栄養
    • 経腸栄養製剤
    • 非経口栄養剤

第6章 臨床栄養の世界市場：適応症別

  • 市場スナップショット
  • 臨床栄養の世界市場：適応症別、実績 - ポテンシャル分析
  • 臨床栄養の世界市場：適応症別、推定・予測（2020年～2030年）
  • 臨床栄養市場のサブセグメント分析
    • アルツハイマー
    • 栄養不足
    • がんケア
    • 糖尿病
    • 慢性腎臓病
    • 希少疾患
    • 嚥下障害
    • 疼痛管理
    • 吸収不良/胃腸障害/下痢
    • その他

第7章 臨床栄養の世界市場：販売チャネル別

  • 市場スナップショット
  • 臨床栄養の世界市場：販売チャネル別、実績 - ポテンシャル分析
  • 臨床栄養の世界市場：販売チャネル別、推定・予測（2020年～2030年）
  • 臨床栄養市場のサブセグメント分析
    • 小売販売チャネル
    • オンライン販売チャネル
    • 企業販売チャネル

第8章 臨床栄養の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 臨床栄養市場：地域別の市場スナップショット
  • 北米
    • 米国
      • 製品別の推定・予測（2020年～2030年）
      • 適応症別の推定・予測（2020年～2030年）
      • 販売チャネル別の推定・予測（2020年～2030年）
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Abbott Nutrition
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Pfizer Inc.
    • Bayer AG
    • Nestle S.A
    • Baxter International Inc.
    • Otsuka Holdings Co., Ltd.
    • Mead Johnson & Company, LLC
    • Danone（Nutricia）
    • Victus, Inc.
    • Fresenius Kabi

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1.Global Clinical Nutrition Market, report scope
  • TABLE 2.Global Clinical Nutrition Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Clinical Nutrition Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4.Global Clinical Nutrition Market estimates & forecasts by Indication 2020-2030 (USD Billion)
  • TABLE 5.Global Clinical Nutrition Market estimates & forecasts by Sales Channel 2020-2030 (USD Billion)
  • TABLE 6.Global Clinical Nutrition Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Clinical Nutrition Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Clinical Nutrition Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Clinical Nutrition Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Clinical Nutrition Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Clinical Nutrition Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Clinical Nutrition Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Clinical Nutrition Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Clinical Nutrition Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Clinical Nutrition Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.Saudi Arabia Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.South Africa Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70.South Africa Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71.RoMEA Clinical Nutrition Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 72.RoMEA Clinical Nutrition Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 73.List of secondary sources, used in the study of global Clinical Nutrition Market
  • TABLE 74.List of primary sources, used in the study of global Clinical Nutrition Market
  • TABLE 75.Years considered for the study
  • TABLE 76.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Clinical Nutrition Market, research methodology
  • FIG 2.Global Clinical Nutrition Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Clinical Nutrition Market, key trends 2022
  • FIG 5.Global Clinical Nutrition Market, growth prospects 2023-2030
  • FIG 6.Global Clinical Nutrition Market, porters 5 force model
  • FIG 7.Global Clinical Nutrition Market, pest analysis
  • FIG 8.Global Clinical Nutrition Market, value chain analysis
  • FIG 9.Global Clinical Nutrition Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Clinical Nutrition Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Clinical Nutrition Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Clinical Nutrition Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Clinical Nutrition Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Clinical Nutrition Market, regional snapshot 2020 & 2030
  • FIG 15.North America Clinical Nutrition Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Clinical Nutrition Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Clinical Nutrition Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Clinical Nutrition Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Clinical Nutrition Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Clinical Nutrition Market is valued at approximately USD 29.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.34% over the forecast period 2023-2030. Clinical nutrition is a specialized branch of nutrition science that focuses on the application of dietary principles to prevent, manage, and treat various health conditions. It involves the assessment of an individual's nutritional needs, dietary habits, and overall health status to develop personalized nutrition plans. Clinical nutritionists work in collaboration with healthcare professionals to address specific medical concerns such as diabetes, cardiovascular diseases, obesity, and gastrointestinal disorders. They utilize their knowledge of biochemistry, physiology, and nutrition to design interventions that support optimal health and well-being. The Clinical Nutrition Market is expanding because of factors such as the rising prevalence of malnutrition, the increase in the prevalence of chronic diseases, and the rising geriatric population around the globe.

The rising prevalence of malnutrition is a significant driver behind the growth of the Clinical Nutrition Market. Malnutrition, characterized by deficiencies or imbalances in essential nutrients, poses a substantial global health challenge, affecting individuals across diverse age groups and populations. In light of the severe consequences of malnutrition, clinical nutrition must be emphasized and implemented as a crucial measure to effectively address and prevent this condition. Clinical nutrition products and interventions play a crucial role in delivering targeted nutritional support to individuals with malnutrition, whether caused by medical conditions, chronic diseases, or inadequate dietary intake. According to the World Health Organization's 2022 report, approximately 149 million children under the age of 5 were identified as stunted globally, with 45 million experiencing malnutrition. The South Asia sub-region bears a substantial burden of malnutrition among children in this age group. The United Nations reports a concerning trend in Asia, where the undernourished population rose from 361.3 million in 2019 to 418.0 million in 2020, leading to an increase in undernourishment from 7.9% to 9.0% during this period. Thus, rising prevalence of malnutrition is driving the market growth. In addition, technological advancements in nutrition science and increasing healthcare infrastructure are creating new opportunities for market growth. However, the high cost of clinical nutrition and stringent regulatory environment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Clinical Nutrition Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. The market in the region is being driven by factors such as the increasing geriatric population, which is more susceptible to chronic diseases, such as gastrointestinal disorders, metabolic disorders, and neurological disorders and the growing number of premature infants in critical care is a major factor driving market growth. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as a rising geriatric population and, an increase in the prevalence of various diseases, such as cancer, diabetes, gastrointestinal disorders, and autoimmune diseases. As a result, the demand for clinical nutrition for the dietary management of chronic diseases is expected to increase.

Major market players included in this report are:

  • Abbott Nutrition (U.S)
  • Pfizer Inc. (U.S)
  • Bayer AG (Germany)
  • Nestle S.A (Switzerland)
  • Baxter International Inc. (U.S)
  • Otsuka Holdings Co., Ltd. (Japan)
  • Reckitt Benckiser Group Plc (UK)
  • Danone (Nutricia) (France)
  • Victus, Inc. (US)
  • Fresenius Kabi (Germany)

Recent Developments in the Market:

  • In March 2023, Danone completed the acquisition of ProMedica, a Poland-based company specializing in offering in-home care services for patients. This strategic move aligns with Danone's robust expansion strategy in the specialized nutrition market, aimed at bolstering its footprint in Poland.
  • In March 2022, the FDA approved Fresenius Kabi for the use of its SMOFlipid Lipid Injectable Emulsion in pediatric patients undergoing parenteral nutrition. The approval provided healthcare providers with an additional treatment option for pediatric patients requiring parenteral nutrition, potentially leading to improved patient outcomes and satisfaction.

Global Clinical Nutrition Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Product, Indication, Sales Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Oral Clinical Nutrition
  • Enteral Feeding Formulas
  • Parenteral Nutrition

By Indication:

  • Alzheimer's
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others

By Sales Channel:

  • Retail Sales Channels
  • Online Sales Channels
  • Institutional Sales Channels

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Clinical Nutrition Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Clinical Nutrition Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3.Clinical Nutrition Market, by Indication, 2020-2030 (USD Billion)
    • 1.2.4.Clinical Nutrition Market, by Sales Channel, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Clinical Nutrition Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Clinical Nutrition Market Dynamics

  • 3.1.Clinical Nutrition Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Rising Prevalence of Malnutrition
      • 3.1.1.2.Increase in Prevalence of Chronic Diseases
      • 3.1.1.3.Upsurge in Geriatric Population
    • 3.1.2.Market Challenges
      • 3.1.2.1.Stringent Regulatory Environment
      • 3.1.2.2.High Cost of Clinical Nutrition Services
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Technological Advancements in Nutrition Science
      • 3.1.3.2.Increasing Healthcare Infrastructure

Chapter 4.Global Clinical Nutrition Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Clinical Nutrition Market, by Product

  • 5.1.Market Snapshot
  • 5.2.Global Clinical Nutrition Market by Product, Performance - Potential Analysis
  • 5.3.Global Clinical Nutrition Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4.Clinical Nutrition Market, Sub Segment Analysis
    • 5.4.1. Oral Clinical Nutrition
    • 5.4.2.Enteral Feeding Formulas
    • 5.4.3.Parenteral Nutrition

Chapter 6.Global Clinical Nutrition Market, by Indication

  • 6.1.Market Snapshot
  • 6.2.Global Clinical Nutrition Market by Indication, Performance - Potential Analysis
  • 6.3.Global Clinical Nutrition Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
  • 6.4.Clinical Nutrition Market, Sub Segment Analysis
    • 6.4.1. Alzheimer's
    • 6.4.2.Nutrition Deficiency
    • 6.4.3.Cancer Care
    • 6.4.4.Diabetes
    • 6.4.5.Chronic Kidney Diseases
    • 6.4.6.Orphan Diseases
    • 6.4.7.Dysphagia
    • 6.4.8.Pain Management
    • 6.4.9.Malabsorption/GI Disorder/Diarrhea
    • 6.4.10.Others

Chapter 7.Global Clinical Nutrition Market, by Sales Channel

  • 7.1.Market Snapshot
  • 7.2.Global Clinical Nutrition Market by Sales Channel, Performance - Potential Analysis
  • 7.3.Global Clinical Nutrition Market Estimates & Forecasts by Sales Channel 2020-2030 (USD Billion)
  • 7.4.Clinical Nutrition Market, Sub Segment Analysis
    • 7.4.1. Retail Sales Channels
    • 7.4.2.Online Sales Channels
    • 7.4.3.Institutional Sales Channels

Chapter 8.Global Clinical Nutrition Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Clinical Nutrition Market, Regional Market Snapshot
  • 8.4.North America Clinical Nutrition Market
    • 8.4.1.U.S. Clinical Nutrition Market
      • 8.4.1.1.Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.Sales Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Clinical Nutrition Market
  • 8.5.Europe Clinical Nutrition Market Snapshot
    • 8.5.1.U.K. Clinical Nutrition Market
    • 8.5.2.Germany Clinical Nutrition Market
    • 8.5.3.France Clinical Nutrition Market
    • 8.5.4.Spain Clinical Nutrition Market
    • 8.5.5.Italy Clinical Nutrition Market
    • 8.5.6.Rest of Europe Clinical Nutrition Market
  • 8.6.Asia-Pacific Clinical Nutrition Market Snapshot
    • 8.6.1.China Clinical Nutrition Market
    • 8.6.2.India Clinical Nutrition Market
    • 8.6.3.Japan Clinical Nutrition Market
    • 8.6.4.Australia Clinical Nutrition Market
    • 8.6.5.South Korea Clinical Nutrition Market
    • 8.6.6.Rest of Asia Pacific Clinical Nutrition Market
  • 8.7.Latin America Clinical Nutrition Market Snapshot
    • 8.7.1.Brazil Clinical Nutrition Market
    • 8.7.2.Mexico Clinical Nutrition Market
  • 8.8.Middle East & Africa Clinical Nutrition Market
    • 8.8.1.Saudi Arabia Clinical Nutrition Market
    • 8.8.2.South Africa Clinical Nutrition Market
    • 8.8.3.Rest of Middle East & Africa Clinical Nutrition Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Abbott Nutrition
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2. Pfizer Inc.
    • 9.3.3.Bayer AG
    • 9.3.4.Nestle S.A
    • 9.3.5.Baxter International Inc.
    • 9.3.6.Otsuka Holdings Co., Ltd.
    • 9.3.7.Mead Johnson & Company, LLC
    • 9.3.8.Danone (Nutricia)
    • 9.3.9.Victus, Inc.
    • 9.3.10.Fresenius Kabi

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption